Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial.
Saved in:
| Title: | Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial. |
|---|---|
| Authors: | Ledermann JA; UCL Cancer Institute, Cancer Research UK & UCL Trials Centre, London, UK. Electronic address: j.ledermann@ucl.ac.uk., Embleton-Thirsk AC; UCL Comprehensive Clinical Trials Unit, London, UK., Perren TJ; Leeds Institute of Medical Research at St James's, Leeds, UK., Jayson GC; Christie Hospital and University of Manchester, Manchester, UK., Rustin GJS; Mount Vernon Cancer Centre, London, UK., Kaye SB; Royal Marsden Hospital, London, UK., Hirte H; Juravinski Cancer Centre, Hamilton, Canada., Oza A; Princess Margaret Cancer Centre, Toronto, Canada., Vaughan M; Christchurch Hospital, Christchurch, New Zealand., Friedlander M; Prince of Wales Clinical School, University of New South Wales, Sydney, Australia., González-Martín A; Clínica Universidad de Navarra, Madrid, Spain., Deane E; UCL Comprehensive Clinical Trials Unit, London, UK., Popoola B; Medical Research Council Clinical Trials Unit at UCL, London, UK., Farrelly L; UCL Cancer Institute, Cancer Research UK & UCL Trials Centre, London, UK., Swart AM; University of East Anglia, Norwich, UK., Kaplan RS; Medical Research Council Clinical Trials Unit at UCL, London, UK., Parmar MKB; Medical Research Council Clinical Trials Unit at UCL, London, UK. |
| Corporate Authors: | ICON6 collaborators |
| Source: | ESMO open [ESMO Open] 2021 Apr; Vol. 6 (2), pp. 100043. Date of Electronic Publication: 2021 Feb 18. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33610123 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ledermann+JA%22">Ledermann JA</searchLink>; UCL Cancer Institute, Cancer Research UK & UCL Trials Centre, London, UK. Electronic address: j.ledermann@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Embleton-Thirsk+AC%22">Embleton-Thirsk AC</searchLink>; UCL Comprehensive Clinical Trials Unit, London, UK.<br /><searchLink fieldCode="AU" term="%22Perren+TJ%22">Perren TJ</searchLink>; Leeds Institute of Medical Research at St James's, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Jayson+GC%22">Jayson GC</searchLink>; Christie Hospital and University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Rustin+GJS%22">Rustin GJS</searchLink>; Mount Vernon Cancer Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Kaye+SB%22">Kaye SB</searchLink>; Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Hirte+H%22">Hirte H</searchLink>; Juravinski Cancer Centre, Hamilton, Canada.<br /><searchLink fieldCode="AU" term="%22Oza+A%22">Oza A</searchLink>; Princess Margaret Cancer Centre, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Vaughan+M%22">Vaughan M</searchLink>; Christchurch Hospital, Christchurch, New Zealand.<br /><searchLink fieldCode="AU" term="%22Friedlander+M%22">Friedlander M</searchLink>; Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22González-Martín+A%22">González-Martín A</searchLink>; Clínica Universidad de Navarra, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Deane+E%22">Deane E</searchLink>; UCL Comprehensive Clinical Trials Unit, London, UK.<br /><searchLink fieldCode="AU" term="%22Popoola+B%22">Popoola B</searchLink>; Medical Research Council Clinical Trials Unit at UCL, London, UK.<br /><searchLink fieldCode="AU" term="%22Farrelly+L%22">Farrelly L</searchLink>; UCL Cancer Institute, Cancer Research UK & UCL Trials Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Swart+AM%22">Swart AM</searchLink>; University of East Anglia, Norwich, UK.<br /><searchLink fieldCode="AU" term="%22Kaplan+RS%22">Kaplan RS</searchLink>; Medical Research Council Clinical Trials Unit at UCL, London, UK.<br /><searchLink fieldCode="AU" term="%22Parmar+MKB%22">Parmar MKB</searchLink>; Medical Research Council Clinical Trials Unit at UCL, London, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ICON6+collaborators%22">ICON6 collaborators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2021 Apr; Vol. 6 (2), pp. 100043. <i>Date of Electronic Publication: </i>2021 Feb 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33610123 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.esmoop.2020.100043 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100043 Titles: – TitleFull: Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ledermann JA – PersonEntity: Name: NameFull: Embleton-Thirsk AC – PersonEntity: Name: NameFull: Perren TJ – PersonEntity: Name: NameFull: Jayson GC – PersonEntity: Name: NameFull: Rustin GJS – PersonEntity: Name: NameFull: Kaye SB – PersonEntity: Name: NameFull: Hirte H – PersonEntity: Name: NameFull: Oza A – PersonEntity: Name: NameFull: Vaughan M – PersonEntity: Name: NameFull: Friedlander M – PersonEntity: Name: NameFull: González-Martín A – PersonEntity: Name: NameFull: Deane E – PersonEntity: Name: NameFull: Popoola B – PersonEntity: Name: NameFull: Farrelly L – PersonEntity: Name: NameFull: Swart AM – PersonEntity: Name: NameFull: Kaplan RS – PersonEntity: Name: NameFull: Parmar MKB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2021 Apr Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2059-7029 Numbering: – Type: volume Value: 6 – Type: issue Value: 2 Titles: – TitleFull: ESMO open Type: main |
| ResultId | 1 |